P2Y12 Receptor Blockade Augments Glycoprotein IIb-IIIa Antagonist Inhibition of Platelet Activation, Aggregation, and Procoagulant ActivityJOURNAL OF THE AMERICAN HEART ASSOCIATIONIF5.32013-05-2015OAAI
The Platelet Activity After Clopidogrel Termination (PACT) StudyCIRCULATION-CARDIOVASCULAR INTERVENTIONSIF7.42010-10-0129PREAI
Response to Letter Regarding Article, Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac CatheterizationCIRCULATIONIF38.62010-08-170OAAI
Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac CatheterizationCIRCULATIONIF38.62009-12-22147PREAI
The platelet hyporeactivity of extremely low birth weight neonates is age-dependentTHROMBOSIS RESEARCHIF3.42009-05-0168PREAI
Effect of adenosine A2 receptor stimulation on platelet activation-aggregation:: Differences between canine and human modelsTHROMBOSIS RESEARCHIF3.42008-01-0129OAAI
Response to letter regarding article, residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistanceCIRCULATIONIF38.62007-01-230OAAI
Cystic fibrosis heterozygotes do not have increased platelet activationTHROMBOSIS RESEARCHIF3.42007-01-013PREAI
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1-and cyclooxygenase-2-independent pathway - A 700-patient study of aspirin resistanceCIRCULATIONIF38.62006-06-27268OAAI